2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow RSV Infection: new trials by email Literature Review of RSV Infection trials Research Report on RSV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) Clesrovimab, Palivizumab, Placebo - RSV Infection | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1003 | 2021-11-30 | 2026-05-08 |
| Effect of Heliox on RSV Bronchiolitis Heliox, Air - RSV Infection, Acute Bronchiolitis | Phase 3 | Completed | Wael Seliem | 104 | 2015-05-01 | 2017-05-31 |
Respiratory Syncytial Virus Infections (2)
Infections (2) · Mononegavirales Infections (2) · Paramyxoviridae Infections (2) · Pneumovirus Infections (2) · RNA Virus Infections (2) · Virus Diseases (2)
Air (1) · MK-1654 (1) · Palivizumab (1) · heliox (1)
Merck Sharp & Dohme LLC (1) · Wael Seliem (1)
Australia (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Hungary (1) · Italy (1) · Japan (1) · Malaysia (1) · Mexico (1)